Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial
Authors
Dearnaley, DGriffin, C.
Syndikus, I.
Khoo, V.
Birtle, A. J.
Choudhury, Ananya
Ferguson, C.
Graham, J.
O'Sullivan, J.
Panades, M.
Rimmer, Y. L.
Scrase, C. D.
Staffurth, J.
Cruickshank, C.
Hassan, S.
Pugh, J.
Hall, E.
Affiliation
Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, LondonIssue Date
2020